[Focal nodular hyperplasia and liver cell adenoma: operation or observation?]
- PMID: 9556887
[Focal nodular hyperplasia and liver cell adenoma: operation or observation?]
Abstract
Patients: In a 15-year period a total of 146 patients underwent surgery for benign hepatic tumors, including 54 focal nodular hyperplasias (FNH) and 23 hepatic cell adenomas (65 hemangioma and 4 cholangioma).
Methods: The medical records of these patients were retrospectively analyzed with respect to tumor-related symptoms, surgical procedures and postoperative complications.
Results: Regardless of the type of the tumor, 70% of the patients had no or only non-specific symptoms. Most frequently, surgery was indicated due to questionable dignity of the lesion (adenoma 70%, FNH 41%). In hepatic cell adenomas (HCA) also perforation or bleeding of the tumor (17%) and severe symptoms (13%) required urgent operation. In two of three cases local excision of the lesion or segmental hepatic resection were performed, whereas extended resection procedures became necessary only in 20 (FNH) to 34% (HCA). The mean duration of postoperative intensive care treatment was significantly shorter in FNH and HCA than in other benign hepatic tumors (1.0 vs. 2.0 days, p < 0.01). After resection of FNH no fatalities or significant complications were observed. In HCA morbidity was 13% without related mortality (hemangioma: 3% mortality; 11% morbidity).
Conclusion: The elective resection of benign hepatic tumors can be achieved with very low mortality and morbidity, and usually provides longterm relief of annoying symptoms. Whenever HCA is suspected surgery should be performed, since severe symptoms and spontaneous hemorrhage (30%) are common in this tumor. Also hepatocellular carcinoma can be excluded only by histologic work-up of the operative specimen. In focal nodular hyperplasia (FNH), complications are rare and malignant transformation does not occur even when observation is employed only. Resection should be restricted to symptomatic or growing tumors with subsequent cholestasis or to cases with uncertain diagnosis.
Similar articles
-
[Diagnosis and surgical therapy of benign liver tumors].Zentralbl Chir. 1994;119(7):495-500. Zentralbl Chir. 1994. PMID: 7941797 German.
-
[Diagnostic and therapeutic strategies in hepatocellular adenoma].Zentralbl Chir. 1998;123(2):140-4. Zentralbl Chir. 1998. PMID: 9556886 German.
-
Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.Am Surg. 2001 Feb;67(2):173-8. Am Surg. 2001. PMID: 11243545
-
Hepatic adenoma and focal nodular hyperplasia.Surg Gynecol Obstet. 1991 Nov;173(5):426-31. Surg Gynecol Obstet. 1991. PMID: 1658955 Review.
-
Hepatic tumors induced by sex steroids.Semin Liver Dis. 1984 May;4(2):147-57. doi: 10.1055/s-2008-1040654. Semin Liver Dis. 1984. PMID: 6087460 Review.
Cited by
-
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.HPB (Oxford). 2010 Oct;12(8):509-22. doi: 10.1111/j.1477-2574.2010.00222.x. HPB (Oxford). 2010. PMID: 20887318 Free PMC article.
-
Management of hemangioma of the liver: surgical therapy or observation?World J Surg. 2013 Jun;37(6):1303-12. doi: 10.1007/s00268-013-1904-1. World J Surg. 2013. PMID: 23354918
-
Diagnosis and management of hepatic focal nodular hyperplasia.J Ultrasound. 2007 Sep;10(3):116-27. doi: 10.1016/j.jus.2007.06.001. Epub 2007 Aug 1. J Ultrasound. 2007. PMID: 23396642 Free PMC article.
-
Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.Updates Surg. 2014 Mar;66(1):9-21. doi: 10.1007/s13304-013-0222-3. Epub 2013 Jun 27. Updates Surg. 2014. PMID: 23807711 Review.
-
Transarterial embolization as a therapeutic option for focal nodular hyperplasia in four patients.Eur Radiol. 2006 Mar;16(3):670-5. doi: 10.1007/s00330-005-2885-8. Epub 2005 Aug 20. Eur Radiol. 2006. PMID: 16132920
Publication types
MeSH terms
LinkOut - more resources
Medical